Kelun Pharmaceutical's first-half net profit reached 1.128 billion yuan, up 12.71% year-on-year

CLS··CN·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Kelun Pharmaceutical released its 2026 semi-annual report. In the first half of the year, it achieved operating revenue of 8.839 billion yuan, down 2.7% year-on-year. Net profit attributable to shareholders of the listed company was 1.128 billion yuan, up 12.71% year-on-year. The company plans to distribute a cash dividend of 0.126 yuan per 10 shares, tax included. Based on calculations, the company's second-quarter net profit was 674 million yuan, up 48% quarter-on-quarter.

Impact on assets 1

Others▲